Respected Times columnist, Libby Purves, took aim last week at the campaigning work of charities (see article (pay-wall)). As did Chris Snowdon, a fellow at the Institute of Economic Affairs (IEA), who wrote this piece in CITYA.M. Both appear to share a romanticised view of charity in which charities would be better ‘seen and not heard.’ And through a soft-focus lens at… Read More Charities should be often seen and loudly heard.
The best advice I can give charity Boards of Trustees today is: lock up your chief executive because the Daily Telegraph is after them. The newspaper known for its successful probing of MP pay and expenses is now taking aim at charity CEOs. Specifically it has gone for the heads of the charities that make… Read More Lock up your charity CEO the Daily Telegraph is coming
It has been in the works for a not inconsiderable amount of time. A slow burner if you like. So it somehow seems fitting that the first flames should flicker almost unnoticed. Yesterday, Research Fortnight’s Adam Smith wrote about a new mental health research charity to be launched next year with a hefty £20 million… Read More Comment piece: New mental health research charity springs from an unlikely quarter #mentalhealth
This is an extract from a talk I gave on Monday to the Faculty of Medical Sciences at the University of Newcastle. I tried to answer the following question: The life sciences are seen as fundamental to the nation’s health and to economic growth. But what is the public’s role in making this happen? The… Read More The life sciences, the public and the growth agenda…its not just about bums on seats
Divvying up the costs of conducting research in the NHS funded by medical research charities is an intricate business. Who pays for that research nurse, their time in administering the extra treatment required in a clinical trial, the procedures and equipment needed as part of its conduct, the oversight and governance needed to ensure that things are done… Read More DH and charities reach acoRD over medical research costs
I thought this short piece by David Shaywitz in US Forbes Magazine was terrific. David examines three problems identified by the pharmaceutical industry as holding them back, and proposes solutions to each. The first seems to follow on neatly from my blog on Saturday which looked at the venture philanthropy tactics being pursued by charities to… Read More Behavioural matters: pharma could learn its way out of its ‘slump’ by working more closely with patients
From The Economist in New York, a short but interesting piece on the growing collaboration between charities, pharmaceutical and biotech companies in the US to bring new drugs to market. More specifically it looks at the ‘venture philanthropy’ model being adopted by charities there to support clinical trials. I’m not quite sure I’d characterise it as… Read More Spirit of ad-venture shown by charities in funding drug research or a sign of desperate times?